MAYNE PHARMA GROUP LIMITED — Capital/Financing Update 2016

Jul 6, 2016

7 July 2016

The Manager Company Notices Section ASX Limited Level 45, South Tower, Rialto Towers 525 Collins Street MELBOURNE VIC 3000

Dear Sir/Madam

Notice under section 708A(5)(e) of the Corporations Act 2001 (Cth)

This notice is given by Mayne Pharma Group Limited ACN 115 832 963 ( Mayne Pharma ) under section 708A(5)(e) of the Corporations Act 2001 (Cth) ( Corporations Act ).

Mayne Pharma has today issued 191,300,000 fully paid ordinary shares in Mayne Pharma ( Placement Shares ) to certain institutional shareholders in accordance with the announcement by Mayne Pharma on 30 June 2016.

Mayne Pharma advises that:

• (a) the Placement Shares were issued without disclosure to investors under Part 6D.2 of the Corporations Act;

• (b) this notice is being given under section 708A(5)(e) of the Corporations Act;

• (c) as at the date of this notice, Mayne Pharma has complied with:

  • (i) the provisions of Chapter 2M of the Corporations Act as they apply to Mayne Pharma; and

  • (ii) section 674 of the Corporations Act; and

• (d) as at the date of this notice, there is no excluded information of the type referred to in sections 708A(7) and 708A(8) of the Corporations Act.

Yours faithfully, Mayne Pharma Group Limited

==> picture [158 x 36] intentionally omitted <==

Mark Cansdale Group CFO and Company Secretary

==> picture [451 x 44] intentionally omitted <==